| Metric | შპს მედ ფარმასი გრუპი | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾1.2m₾1.5m | ₾2.36bn₾2.11bn |
| Revenue growth | -19.6% | 11.8% |
| Profitability | ||
| EBITDA | -₾11k-₾565k | — |
| EBITDA margin | -0.9%-38.3% | — |
| Net profit | -₾48k-₾582k | ₾1.24bn₾1.12bn |
| Net margin | -4.1%-39.5% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾892k₾1.1m | ₾37.66bn₾31.77bn |
| Total equity | ₾672k₾720k | ₾5.45bn₾4.75bn |
| ROE | -7.2%-80.9% | 22.8%23.6% |